In contrast, live-attenuated influenza vaccines (LAIVs) are cold-adapted reassortant vaccines made with genes encoding for HA and NA proteins of the most recent seasonal or wild-type strain, and six additional gene segments from attenuated donor strains [76,112]. The gene discussed is XK; the disease is influenza.